Somatostatin Analogues: Treatment of Pituitary and Neuroendocrine Tumors

This publication has 66 references indexed in Scilit:

• Acromegaly pathogenesis and treatment
  Journal of Clinical Investigation, 2009
• Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
  Cancer, 2008
• The role of somatostatin analogues in the treatment of neuroendocrine tumours
  Molecular and Cellular Endocrinology, 2008
• Gastroenteropancreatic neuroendocrine tumours
  The Lancet Oncology, 2008
• Beneficial effect of dose escalation of Octreotide-LAR as first-line therapy in patients with acromegaly
  European Journal of Endocrinology, 2007
• A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR^® (long‐acting repeatable octreotide) in the primary therapy of patients with acromegaly
  Clinical Endocrinology, 2007
• Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution
  Clinical Endocrinology, 2005
• The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
  Endocrine Reviews, 2004
• Octreotide Long-Acting Release (LAR)
  Drugs, 1997
• Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin Analogue
  New England Journal of Medicine, 1987